BOLTON SECURITIES CORPORATION’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding LENZ
BOLTON SECURITIES CORPORATION's LENZ Position: Q3 2026 in Review
BOLTON SECURITIES CORPORATION held its LENZ Therapeutics (LENZ) position steady in Q3 2026 at 7,000 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1541.
BOLTON SECURITIES CORPORATION first reported a position in LENZ in Q1 2026 and has held it in 3 quarters since. The position peaked at $64K in Q1 2026. 91 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.
- BOLTON SECURITIES CORPORATION held 7,000 shares of LENZ Therapeutics worth $26.9K as of Q3 2026.
- BOLTON SECURITIES CORPORATION left its LENZ Therapeutics share count unchanged in Q3 2026.
- LENZ Therapeutics made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1541 holding.
- BOLTON SECURITIES CORPORATION first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 3 quarters since.
- BOLTON SECURITIES CORPORATION's LENZ Therapeutics position peaked at $64K in Q1 2026.
- 91 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.
Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.